# clm_EA59F20B3B9B

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: shares_outstanding  
value: 956,580,893 shares  
valid_from: 2021-07-30  
valid_to: 2021-10-22  
published: 2021-08-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_AD43BA302B07  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company shares outstanding: 956,580,893 shares", as of 2021-07-30 (until 2021-10-22). Claim clm_EA59F20B3B9B, https://asof.is/claim/clm_EA59F20B3B9B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/0000059478-21-000171-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-08-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/0000059478-21-000171-index.htm (primary, SEC EDGAR 10-Q Q2 FY2021, published 2021-08-03)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | shares_outstanding | 959,025,446 shares | valid 2021-04-27 to 2021-07-30 | conf 0.95 | superseded | superseded_by [clm_EA59F20B3B9B](/claim/clm_EA59F20B3B9B.md) | [clm_3086AC877E4A](/claim/clm_3086AC877E4A.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.